Suppr超能文献

[结核病中的外源性再感染]

[Exogenous re-infection in tuberculosis].

作者信息

Tsuchiya Toshiaki

机构信息

Department of Respiratory Center, National Hospital Organization Nishi-Niigata Chuo National Hospital, Japan.

出版信息

Kekkaku. 2006 Feb;81(2):79-91.

Abstract

Patients infected by tuberculosis (TB) had been thought to never experience exogenous re-infection. However, exogenous re-infection in HIV-positive patients is well known. Thanks to the introduction of histopathological examination, analysis of similarities in drug-resistance patterns and epidemiological surveys of genetic phage typing for TB infection, we have begun to understand that even people with a normal immune system can experience re-infection. Recent advances in the techniques of restriction fragment length polymorphism (RFLP) and spoligotyping allow determination of similarities in tubercle bacilli, revealing a high ratio of exogenous re-infection. In this mini-symposium, Dr. Kazunari Tsuyuguchi reported cases of nosocomial multidrug-resistant tuberculosis (MDRTB) infection, as exogenous re-infection, at 3 tuberculosis hospitals in the Osaka area. Although the virulence of MDRTB as a variant strain has generally been regarded as weaker than that of drug-sensitive strains, he reported even non-Beijing strain MDRTB, which displays strong virulence, could possess possible infectiosity with a 42% ratio of clustering formation and 2 of 8 patients with MDRTB exhibiting exogenous re-infection, as analyzed by RFLP. Dr. Hideo Ogata reported the actual condition of exogenous re-infection, having cited a large number of reports at home and abroad. In his report he indicated that even among hosts without serious hypoimmunity, re-infection rate is high in high-prevalence countries. Conversely, endogenous TB reactivation is high in low-prevalence countries. As Japan has become a low-prevalence country, endogenous reactivation might be seen in TB wards. Dr. Katsuhiro Kuwabara reported on his study about exogenous re-infection of Mycobacterium avium, which represented resident flora in the environment, using IS1245 RFLP analysis. He demonstrated that re-infection and multiple infections were frequently observed in M. avium infection. Dr. Tomoshige Matsumoto finally added that about 90% of patients with recurrence in the Osaka area exhibit endogenous reactivation, as found using molecular epidemiologic analysis of bacterial strains from initially treated and retreated patients. Compared with reports from other countries, the ratio of exogenous re-infection in Japan is lower than elsewhere. Thanks to the public health service about TB, sources of TB infection are not present, so patients with TB do not experience exogenous re-infection, he concluded. He also discussed the variable number of tandem repeats (VNTR)-typing method that has been taking the place of the IS6110 RFLP. In this mini-symposium referring to molecular epidemiological analyses and reports from Japan and overseas, we showed that depending on factors involving hosts, parasites and the density of TB re-exposure, the possibility of universal exogenous nosocomial re-infection exists. Each presenter alerted us to the fact that as exogenous re-infection occurs mainly in TB inpatient wards, prevention of TB infection is crucial for inpatients and medical staff in Japan as a low-prevalence country. (1) Exogenous re-infection by multidrug-resistant tuberculosis: Kazunari TSUYUGUCHI, Shiomi YOSHIDA, Katsuhiro SUZUKI, Masaji OKADA, Mitsunori SAKATANI (NHO Kinki-chuo Chest Medical Center) We describe three recurrent cases of multidrug-resistant (MDR) tuberculosis (TB) nosocomially re-infected with MDRTB strain during treatment for drug-sensitive TB. The first and the second patients, both of whom were middle-aged heavy smoker men, were associated with the outbreak caused by non-Beijing MDRTB strain. The third patient was a immunocompetent young man and the isolated strain was Beijing MDRTB strain. All the patients were HIV-seronegative. We conclude that exogenous re-infection by MDRTB can occur on various situations. These results underscore the importance of placing MDRTB patients separately from drug-sensitive TB patients. (2) Reviews of the exogenous re-infection in tuberculosis: Hideo OGATA (Fukujuji Hospital, JATA) In Japan, they have thought that a tubercular relapse is based on endogenous reactivation in almost all cases. However, there are many studies which prove exogenous re-infection using tuberculin test or drug susceptibility test. The technique of developed strain typing contributed exogenous re-infection to clarifying greatly in a real proof and its frequency in recent years. (3) Multiple and repeated polyclonal infections in patients with Mycobacterium avium lung diseases: Katsuhiro KUWABARA (NHO Nishi-Niigata Chuo National Hospital) The routes of transmission and environmental reservoirs of Mycobacterium avium infections have been unclear. IS1245 based RFLP analysis showed genetic diversity of Mycobacterium avium clinical isolates and the relation between clinical subtype and polyclonal infection. Our study demonstrates that polyclonal infections are common in Mycobacterium avium lung diseases, especially nodular bronchiectasis type. In addition, not only simultaneous polyclonal infections but also repeated polyclonal infections were observed in some patients. The knowledge of polyclonal infection will lead to better understanding of Mycobacteriuim avium pathogenesis and epidemiology. SPECIAL COMMENTARIES: Consideration of exogenous re-infection of tuberculosis in Osaka. Japan, by using molecular epidemiologic tools: Tomoshige MATSUMOTO (Osaka Prefectural Medical Center for Respiratory and Allergic Diseases) By using IS6110 RFLP, we showed that 9.5% of TB recurrence was caused by re-infection in the middle-eastern area of Osaka Prefecture, Japan. The molecular typing tools are now being applicable not only to epidemiological but also to clinical fields by an introduction of PCR-based method, such as Variable Numbers of Tandem Repeats (VNTR) typing. We showed some examples about usefulness of the clinical application of molecular epidemiology, using VNTR.

摘要

曾认为感染结核病(TB)的患者不会发生外源性再感染。然而,HIV阳性患者的外源性再感染却是众所周知的。由于引入了组织病理学检查、耐药模式相似性分析以及结核感染基因噬菌体分型的流行病学调查,我们开始明白,即使是免疫系统正常的人也可能发生再感染。限制性片段长度多态性(RFLP)技术和间隔寡核苷酸分型技术的最新进展能够确定结核杆菌的相似性,揭示出较高比例的外源性再感染。在本次小型研讨会上,津口一也博士报告了大阪地区3家结核病医院发生的医院内耐多药结核病(MDRTB)感染病例,这些病例属于外源性再感染。尽管MDRTB作为一种变异菌株,其毒力通常被认为比药物敏感菌株弱,但他报告称,即使是非北京型MDRTB菌株,其毒力很强,通过RFLP分析发现,其聚集形成率为42%,8例MDRTB患者中有2例表现为外源性再感染,具有潜在传染性。绪方英夫博士引用了大量国内外报告,介绍了外源性再感染的实际情况。他在报告中指出,即使在没有严重免疫低下的宿主中,高流行国家的再感染率也很高。相反,低流行国家的内源性结核再激活率很高。由于日本已成为低流行国家,在结核病病房可能会出现内源性再激活。桑原克洋博士报告了他利用IS1245 RFLP分析对环境中作为常驻菌群的鸟分枝杆菌外源性再感染的研究。他证明,在鸟分枝杆菌感染中经常观察到再感染和多重感染。松本智重博士最后补充说,通过对初治和复治患者的菌株进行分子流行病学分析发现,大阪地区约90%的复发患者表现为内源性再激活。与其他国家的报告相比,日本外源性再感染的比例低于其他地方。他总结说,由于结核病的公共卫生服务,结核病感染源不存在,因此结核病患者不会发生外源性再感染。他还讨论了已取代IS6110 RFLP的可变数目串联重复序列(VNTR)分型方法。在本次涉及分子流行病学分析以及日本和海外报告的小型研讨会上,我们表明,取决于宿主、寄生虫和结核再暴露密度等因素,普遍存在外源性医院内再感染的可能性。每位演讲者都提醒我们,由于外源性再感染主要发生在结核病住院病房,作为低流行国家,日本的住院患者和医务人员预防结核病感染至关重要。

(1)耐多药结核病的外源性再感染:津口一也、吉田史绪美、铃木克洋、冈田正治、坂谷光德(国立医院机构近畿中央胸部医疗中心)

我们描述了3例耐多药(MDR)结核病患者在治疗药物敏感结核病期间发生医院内MDRTB菌株再感染的复发病例。第一例和第二例患者均为中年重度吸烟男性,与非北京型MDRTB菌株引起的暴发有关。第三例患者是一名免疫功能正常的年轻人,分离出的菌株是北京型MDRTB菌株。所有患者HIV血清学检测均为阴性。我们得出结论,MDRTB的外源性再感染可在各种情况下发生。这些结果强调了将MDRTB患者与药物敏感结核病患者分开安置的重要性。

(2)结核病外源性再感染综述:绪方英夫(福住寺医院,日本结核病协会)

在日本,人们一直认为几乎所有的结核复发都是基于内源性再激活。然而,有许多研究通过结核菌素试验或药物敏感性试验证明了外源性再感染。近年来,菌株分型技术的发展极大地有助于从实际证据和频率上阐明外源性再感染。

(3)鸟分枝杆菌肺病患者的多重和重复多克隆感染:桑原克洋(国立医院机构新潟中央西部医院)

鸟分枝杆菌感染的传播途径和环境储存库尚不清楚。基于IS1245的RFLP分析显示了鸟分枝杆菌临床分离株的遗传多样性以及临床亚型与多克隆感染之间的关系。我们的研究表明,多克隆感染在鸟分枝杆菌肺病中很常见,尤其是结节性支气管扩张型。此外,在一些患者中不仅观察到同时发生的多克隆感染,还观察到重复的多克隆感染。对多克隆感染的了解将有助于更好地理解鸟分枝杆菌的发病机制和流行病学。

特别评论

利用分子流行病学工具对日本大阪结核病外源性再感染的思考:松本智重(大阪府立呼吸与过敏性疾病医疗中心)

通过使用IS6110 RFLP,我们发现日本大阪府中部地区9.5%的结核复发是由再感染引起的。通过引入基于PCR的方法,如可变数目串联重复序列(VNTR)分型,分子分型工具现在不仅适用于流行病学领域,也适用于临床领域。我们展示了一些使用VNTR进行分子流行病学临床应用的有用示例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验